Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS 0.00%·Rev n/aQ4 24EPS +50.00%·Rev n/aQ3 24EPS -14.29%·Rev n/aQ2 24EPS +54.00%·Rev n/a⚠ consensus missing

Iterum Therapeutics plc ITRMF

Louise Barrett — SVP of Legal Affairs

Corey Fishman — Chief Executive Officer

Judy Matthews — CFO or Financial Officer

−7.1%1d on move date−7.8% vs SPY3d−8.1%5d−1.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ITRMF calls or request research access.

More ITRMF calls Browse calls Request research access